Remdesivir for treatment of COVID-19 patients

Remdesivir for treatment of COVID-19 patients

Coronavirus, Therapeutic

90 Minutes

English Site

Recorded Webinar


Course Overview


Remdesivir, is approved in India for the treatment of suspected or laboratory confirmed incidences of COVID-19 in adults and children hospitalized with severe presentations of the disease.

The COVID-19 disease is relatively new and as this drug has seen significant usage in hospitalized patients, there is a need for clinicians to share their experiences on the topic. Indian Medical Association - Tamil Nadu (IMA TNSB), welcomes doctors to an recorded informative session on "Remdesivir for treatment of COVID-19 patients".

"0.5 CME credit was awarded by TNMC"

IMA Highlights Tamil Nadu  

Module 1: Clinical experience with different treatment options (Dr. Nandagopal Velayuthaswamy)  
●Present situation of COVID-19 and quires to disease related addressed   
●RT-PCR the Gold Standard for Diagnosis of COVID19 discussed  

Case presentations with discussion on  
●History and investigation  
●Radiological markers explained with examples 
●Inflammatory markers  
●Treatment given 
●Recurrence of symptoms and management 
●Very early phase tests may be negative  
●Consider duration of illness for testing  
●Don’t hesitate to repeat tests 
●Always consider switching treatment medications if no clinical improvement  
Module 2: Remdesivir in COVID19 - Current status and Practical Issues (Dr Ravindra Mehta) 
●Proven treatment stratergies  
●Anti – inflammatory therapy Steroids  
●Discussion on remdesivir and positives and negatives of usage from literature review and personal experience discussed  
Module 3: Clinical studies, treatment current experience & expectation from the near future (Dr M.N. Sivakumar) 
●Literature review of COVID -19 and Remdesivir  
●Personal experience of use of Remdisivir at RCH hospital explained  
Module 4:  
Question raised addressed in interactive session  

We wish you a great learning experience and thank our sponsors Mylan Pharmaceuticals Pvt. Ltd. to make this program possible. 


Contact Us
Thank you for showing interest in Remdesivir for treatment of COVID-19 patients. We are sorry that the course is unavailable at the moment. Please leave your contact details and we will notify you of related courses or upcoming dates.